These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3204655

  • 1. [Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1988 Oct; 41(10):1418-29. PubMed ID: 3204655
    [Abstract] [Full Text] [Related]

  • 2. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [Abstract] [Full Text] [Related]

  • 3. [Clinical laboratory approach for estimating effective administrative dose of cefuzonam. Evaluation of disc susceptibility test and its interpretation system].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Oct; 41(10):1407-17. PubMed ID: 3204654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical laboratory approach to estimate effective administrative dose of minocyclin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1990 Sep; 43(9):1545-58. PubMed ID: 2262962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1989 Sep; 42(9):1888-99. PubMed ID: 2810752
    [Abstract] [Full Text] [Related]

  • 10. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G, Matsuo K, Uete T.
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical laboratory approach for estimating effective administrative dose of cefsulodin].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1984 Sep; 37(9):1652-60. PubMed ID: 6439909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.